Tg Therapeuticscmn (TGTX)

These seven top stocks all boast substantial support from the Street. But that's not all ... they also have massive upside potential for the next few months, making these stocks a perfect choice to boost your 2018 portfolio performance.

The 7 Best Stocks From Each Sector of Q1

By Harriet Lefton, Writer, TipRanks Mar 26, 2018

Which stocks really blossomed in the first quarter of 2018? Here I single out the seven best-performing stocks of Q1 -- one from each sector. Looking forward, I turn to the Street to assess whether these seven picks still make compelling investing opportunities.

5 ‘Strong Buy’ Biotechs That Can Double in 2018

By Harriet Lefton, Writer, TipRanks Mar 14, 2018

Here are five 'Strong Buy' biotech stocks with potential upside of over 100%. These five innovative stocks are worth tracking over the coming months according to the Street.

7 Hot Healthcare Stocks Set to Double in 2018

By Harriet Lefton, Writer, TipRanks Dec 26, 2017

These seven healthcare stocks have full marks from the Street. Here's a closer look at what makes these stocks so special.

TG Therapeutics Inc (TGTX) Stock Soars on Leukemia Drug Study Results

By Karl Utermohlen, InvestorPlace Writer Mar 6, 2017

TG Therapeutics Inc (TGTX) shares skyrocketed more than 80% Monday as one of the company's drugs reached a new Phase III target and FDA approval may be next.

22 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 11, 2016

This week, 22 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

19 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 4, 2016

The overall ratings of 19 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Why TG Therapeutics Stock Was Rocketing Higher This Week

From The Motley Fool May 3, 2024

The company raised guidance for sales of its drug for relapsing multiple sclerosis.

TG Therapeutics stock jumps after Q4 beat (NASDAQ:TGTX)

From Seeking Alpha Feb 28, 2024

TG Therapeutics (TGTX) stock soars on better-than-expected Q4 2023 financials. Read more here.

TG Therapeutics Q4 2023 Earnings Preview (NASDAQ:TGTX)

From Seeking Alpha Feb 27, 2024

TG Therapeutics is set to announce Q4 earnings results on February 28th.

TG Therapeutics prelim results sees FY23 BRIUMVI U.S. revenue $89M; initiates FY24 outlook

From Seeking Alpha Jan 10, 2024

Ahead of the the ongoing annual J.P. Morgan Healthcare Conference, shares of Therapeutics (TGTX) jumped more than 10% in early trading on Wednesday after the biopharmaceutical company issu

Why TG Therapeutics Stock Is Crushing It Today

From The Motley Fool Nov 1, 2023

The biopharmaceutical company's Q3 update was music to investors' ears.

Why TG Therapeutics Stock Is Crashing Today

From The Motley Fool Aug 1, 2023

The drugmaker delivered a couple of surprises in Q2.

Tg Therapeuticscmn (TGTX)

TGTX Stock Earnings: TG Therapeutics Misses EPS, Beats Revenue for Q1 2024

7 Exciting Stocks Poised for Explosive Growth in Key Sectors

3 Very Oversold Biotech Stocks to Buy Right Now

Why Is TG Therapeutics (TGTX) Stock Down 50% Today?

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Tg Therapeuticscmn (TGTX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

TGTX Stock Predictions, Articles, and Tg Therapeuticscmn News

Subscriber Sign in